New obesity guidelines underscore multifaceted approach
Access to the full content of this site is available only to registered healthcare professionals.
Register to read more
The guidelines outline how to develop a comprehensive plan for the real-world management of obesity, including screening, diagnosis, evaluation, selection of therapy, treatment goals, and individualization of care.
The guidelines were jointly developed by the American Association of Clinical Endocrinologists and the American College of Endocrinology.
They address 9 clinical questions with 123 numbered recommendations and 160 specific statements.
Overall, 53.1% of the statements are strong (Grade A), 30.0% are intermediate (Grade B), 6.9% are weak (Grade C), and 10.0% are based on expert opinion (Grade D).
83.1% of statements are based on strong or intermediate levels of scientific substantiation, defined as a best evidence level of 1 or 2.
The guidelines endorse obesity as a complex, adiposity-based chronic disease.
Optimal management targets both the adiposity and weight-related complications to improve patients’ overall health and quality of life.